New 2015 HOPPS ruling cuts into PET payments

The Centers for Medicare & Medicaid Services (CMS) issued final rules for the 2015 Hospital Outpatient Prospective Payment System (HOPPS) and the Medicare Physician Fee Schedule (MPFS). The rules were recorded in the Federal Register Nov. 10 and go into effect Jan. 1, 2015. It appears that changes to HOPPS will depress PET payments by 1.9 percent.  

Even though the HOPPS conversion factor for 2015 has been increased 2.2 percent to $74.144, CMS is subjecting hospitals to certain quality measures that, if not satisfied, will result in a 2 percent reduction in the conversion factor to $72.661.

IBA Molecular today provided radiopharmaceutical stakeholders with a breakdown of the financial impact of the recent ruling and noted that HOPPS payments for PET procedures are set to undergo a decrease of 1.9 percent in 2015. Most procedures involving PET, including whole-body PET, myocardial perfusion imaging, brain PET and whole-body PET/CT will be paid at the level of $1,285.72 in 2015, vs. the $1,310.60 that has been paid in 2014.  

Excluding diagnostic radiopharmaceuticals with pass-through status, all payments for diagnostic agents will be packaged as usual, including drugs used in myocardial stress tests. Therapeutic radionuclide drugs will be paid separately based on average sales price plus 6 percent.

The MPFS is not expected to change the current pay scale for PET, but U.S. Congress will have to intervene before April of next year or nuclear medicine procedures will suffer a 21.2 percent loss in payments due to a drop in the conversion factor from $35.80 to $28.22, according to the IBA report.

The new HOPPS and MPFS rules were first announced Oct. 31, at which time a comment period was initiated that continues until Dec. 30.

 

 

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup